Form D · Biotechnology

BI02 MEDICAL, INC.

Helotes, TX · CIK 0001410485

Offering snapshot reported Mar 31, 2017 · SEC filing

Reported sold
$1.5M
Offering amount: $8M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 18, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 31, 2017Initial$1,500,000No comparison1SEC filing
Jul 10, 2015Initial$4,000,000No comparison1SEC filing
Mar 14, 2014Initial$5,873,199No comparison10SEC filing
Sep 5, 2012Initial$11,921,539No comparison30SEC filing
Aug 11, 2011Initial$4,576,769No comparison66SEC filing
May 4, 2010Amendment$6,697,942$151,201vs Apr 15, 201057SEC filing
Apr 15, 2010Initial$6,546,741No comparison51SEC filing
Apr 13, 2010Amendment$1,000,000$400,000vs Oct 13, 20098SEC filing
Oct 13, 2009Initial$600,000No comparison2SEC filing
Aug 20, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-283782

Source: Form D, filed Mar 31, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Luis Angel Director, Executive
Steven Bailey Director
Christopher Banas Director, Executive
Paul Castella Director
John Creecy Director
Alan Dean Director
John Elwood Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
12274 Bandera Road Suite 211
Helotes, TX, 78023